Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
234.7 BRL | +0.35% | -2.10% | +20.06% |
05-29 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
05-29 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Its low valuation, with P/E ratio at 8.89 and 8.62 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+20.06% | 78.12B | - | ||
-6.74% | 64.38B | B | ||
+20.58% | 50.09B | A- | ||
-1.50% | 7.15B | A- | ||
-15.08% | 5.57B | A- | ||
-5.00% | 2.43B | C- | ||
-5.90% | 2.31B | C- | ||
-37.75% | 1.51B | - | ||
-9.51% | 1.2B | D+ | ||
-18.50% | 1.17B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MO Stock
- MOOO34 Stock
- Ratings Altria Group, Inc.